Isabelle Soubeyran

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

Lucile Vanhersecke, Maxime Brunet, Jean‐Philippe Guégan et al. · Nature Cancer · 2021 · 569 citations · Full text

Life Sciences, Immunology, Oncology +17

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

Camille Laurent, Marine Baron, Nadia Amara et al. · Journal of Clinical Oncology · 2017 · 217 citations

Medicine, Oncology, Pathology +17

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas

Nathalie Gachard, Marie Parrens, Isabelle Soubeyran et al. · Leukemia · 2012 · 174 citations

Life Sciences, Genetics, Oncology +17

Genomics to select treatment for patients with metastatic breast cancer

Fabrice André, Thomas Filleron, Maud Kamal et al. · Nature · 2022 · 168 citations

Medicine, Bioinformatics, Oncology +12

CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics

Sophie Le Guellec, Isabelle Soubeyran, Philippe Rochaix et al. · Modern Pathology · 2012 · 161 citations · Full text

Veterinary Medicine, Oncology, Pathology +17